Screener
Phathom Pharmaceuticals, Inc. PHAT Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$13.9M+53.6% | -$17.58M+76.8% | -$30.37M+67.8% | -$21.15M+71.6% | -$29.97M+65.0% | ||
| $120K-23.1% | $114K-33.7% | $110K-37.9% | $128K-33.7% | $156K-18.3% | ||
| $5.92M-36.3% | $6.71M-18.9% | $5.53M-0.1% | $5.61M-16.1% | $9.3M+65.0% | ||
| —— | -$1.93M+96.9% | -$15.65M+81.6% | -$5M+92.1% | -$14.12M+77.8% | ||
| $110K+307% | $44K-54.6% | $61K+239% | $87K+1,640% | $27K-38.6% | ||
| -$110K-307% | -$44K+54.6% | -$61K-239% | -$87K-1,640% | -$27K+38.6% | ||
| —— | —— | $173.25M— | $0-100% | $0— | ||
| —— | —— | $229.05M— | —— | —— | ||
| $351K+230% | $3.55M+4,339% | $66.64M— | -$97K-100% | -$271K-100% | ||
| $2.08M+114% | $1.58M+103% | $50.93M+160% | -$5.19M+86.1% | -$14.41M— |
FAQ
- Where does Phathom Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
